Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptors targeted to PSCA

Chimeric antigen receptors targeted to PSCA

US Patent 11466097 · Granted Oct 11, 2022

Estimated economic value: $3,242,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CAR for treatment of HIV infection2025
CS1 targeted chimeric antigen receptor-modified T cells2025
Use of triplex CMV vaccine in CAR T cell therapy2025
Administration of engineered T cells for treatment of cancers in the central ner2025
Administration of engineered T cells for treatment of cancers in the central ner2025
Targeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 pos2025
Oncolytic virus expressing a car T cell target and uses thereof2025
Oncolytic virus expressing a car T cell target and uses thereof2025
CD6 targeted chimeric antigen receptors for treatment of certain autoimmune diso2025
TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG722025
TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG722025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024